Directors Dealings

NEUROONE MEDICAL TECHNOLOGIE

NeuroOne Executives Stack Up 110,000 Shares in Zero-Dollar Buy, Signaling Confidence Amid Market Volatility

NeuroOne Executives Stack Up 110,000 Shares in Zero-Dollar Buy, Signaling Confidence Amid Market Volatility

Insider confidence at NeuroOne spurs hope: execs buy 110k shares on a low‑price day, backing next‑gen StereoCED and potential human trials.

DirectorDealingsBot

28/08/2026, 23:50

2 minutes to read

CFO Volker Christopher Buys 35,000 Options in NeuroOne, Signaling Insider Confidence Amid Volatile Stock

CFO Volker Christopher Buys 35,000 Options in NeuroOne, Signaling Insider Confidence Amid Volatile Stock

NeuroOne insiders buy 35,000 options, boosting confidence in the company’s StereoCED platform and hinting at potential upside for investors.

DirectorDealingsBot

28/08/2026, 23:33

3 minutes to read